Scholarlink

<p>The aim of this study was to evaluate biomarkers of zinc and copper status in patients with thyroid nodules. A cross-sectional study of 122 participants with thyroid nodules, diagnosed with cytological examinations (Nodule group) and 72 healthy subjects (Control group) were performed. Anthropometric data were collected; plasma concentrations of zinc and copper were analyzed by flame atomic absorption spectrophotometry and erythrocyte superoxide dismutase (SOD) activity was determined in an automatic biochemical analyzer using spectrophotometry to quantify the enzyme activity. The content of Zn in plasma was lower in the Nodule group than in the Control group, but plasma copper, copper/zinc ratio and erythrocyte SOD activity were higher in the Nodule group (<i>p</i> &lt; 0.001). The levels of Cu and Zn are in the normal range, but the ratio Cu/Zn is altered in nodules group. Thyroid nodule patients exhibited changes in zinc and copper biomarker status compared to healthy individuals. The Cu/Zn ratio is a much more sensitive parameter for evaluating mineral metabolism in thyroid diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Copper/zinc ratio and erythrocyte superoxide dismutase in patients with thyroid nodules

  • 期刊论文

  • 发表日期：

    2025年9月22日

查看全文
  • Bruna Aparecida Melo Batista,
  • Matheus Aragão Dias Firmino,
  • Paula Alexandre de Freitas,
  • Morgana Pinheiro Sousa,
  • Ana Carolina Marinho Ferreira,
  • André Pires Cortez,
  • Wladiana Oliveira Matos,
  • Francisco Luan Fonsêca da Silva,
  • Carla Soraya Costa Maia

摘要

The aim of this study was to evaluate biomarkers of zinc and copper status in patients with thyroid nodules. A cross-sectional study of 122 participants with thyroid nodules, diagnosed with cytological examinations (Nodule group) and 72 healthy subjects (Control group) were performed. Anthropometric data were collected; plasma concentrations of zinc and copper were analyzed by flame atomic absorption spectrophotometry and erythrocyte superoxide dismutase (SOD) activity was determined in an automatic biochemical analyzer using spectrophotometry to quantify the enzyme activity. The content of Zn in plasma was lower in the Nodule group than in the Control group, but plasma copper, copper/zinc ratio and erythrocyte SOD activity were higher in the Nodule group (p < 0.001). The levels of Cu and Zn are in the normal range, but the ratio Cu/Zn is altered in nodules group. Thyroid nodule patients exhibited changes in zinc and copper biomarker status compared to healthy individuals. The Cu/Zn ratio is a much more sensitive parameter for evaluating mineral metabolism in thyroid diseases.